← Back to Search

Behavioral Intervention

Contingency Management for Schizophrenia

N/A

Waitlist Available

Led By Martin Paulus, MD

Research Sponsored by Laureate Institute for Brain Research, Inc.

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Diagnosis of Schizophrenia Spectrum, Bipolar, or Related Disorders

Age 18-65 years old

Must not have

Cognitive impairment that would interfere with participation in the study

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 18 months

Awards & highlights

No Placebo-Only Group

Summary

"This trial aims to see if giving money incentives to mentally ill homeless individuals with schizophrenia or bipolar disorder can help reduce their disruptive behaviors in the community. Up to 15 participants will meet weekly with their case

Who is the study for?

This trial is for unhoused individuals in Tulsa with schizophrenia or bipolar disorder who also have anosognosia, meaning they're not aware of their mental health condition. Participants should display problematic behaviors and will work with a case manager weekly.

What is being tested?

The study tests if giving money can help reduce disruptive behaviors in the participants. They get $10 for discussing life goals and an extra $20 for trouble-free weeks, which increases by $1 each successful week.

What are the potential side effects?

Since this trial involves monetary incentives rather than medication, traditional side effects are not expected. However, there may be psychological impacts from receiving or failing to receive the incentives.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have been diagnosed with a condition within the schizophrenia spectrum, bipolar disorder, or a related disorder.

Select...

I am between 18 and 65 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

My thinking or memory problems do not prevent me from participating in studies.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 18 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~18 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 18 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Secondary study objectives

Reduction in disruptive behaviors

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Contingency ManagementExperimental Treatment1 Intervention

Meet weekly for 30 minutes with their case manager to discuss progress on life goals ($10) and for having seven days with no disruptive behaviors (or "trouble-free days") per week at each visit, they will receive an additional baseline payment of $20, increasing with continued success in subsequent weeks by $1 per week.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Contingency Management

2014

Completed Phase 4

~3440

0 / 3Eligibility criteria met